STYLIKE GOVERNANCE EXCHANGES
Therapeutic targeting of mitochondria has a great potential in:
- Cancer
- Neurodegenerative disease
- Diabetes
- Aging
METAVERSE CAPITAL EXCHANGES
Drug Discovery
- Screening of metabolic drug libraries
- Identification of the most potent candidates
- Investigation of the mechanism of action
- Identification and optimization of synergistic drug combinations
Medicine Choice
- We screen a sample of patient’s cells and determine which metabolic drug will be the best-suited for this patient.
Research On Metabolism
- We determine how mitochondrial function reacts to various metabolites, stress conditions, genetic mutations and more.
We don’t stop after mitochondrial screening. Learn more about our additional services:
deep data analysisWe Use Imaging-Based Approach To Compare How Mitochondria React To Different Drugs, Metabolites, Stress Conditions And So On.
You Have A Free Choice Of What To Test!
CHIP EXCHANGE
We can screen up to 96 conditions simultenously. Conditions can imply: different drugs, different metabolites, different concentrations, different patient samples, and so on
SENSITIVITY
We can detect changes of even small metabolic stimuli (e.g. micromolar concentrations of fatty acids)
We help you to design screening that is specifically optimized to your goals – technical questions, balance of sensitivity and throughput, and more
Miphic uses imaging-based approach (it is not a bulk method), so we can work with a very low amount of cells.
- Deep analysis of complex data
- Drug sensitivity prediction models
- Correlation between different metabolic parameters and drug sensitivity
- Combination of mitochondrial screening with the complementary data (genetic profiles, medical records and so on)